Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Retatrutide is the developmental designation for an investigational compound owned by Eli Lilly and Company
TB-500 + BPC-157 TB-500 + BPC-157 is een dual-peptide blend die het actine-sequestrerende fragment van thymosine 4 (Ac-LKKTETQ) combineert met het stabiele gastric pentadecapeptide BPC-157, voor onderzoek naar complementaire mechanismen van celmigratie, angiogenese en weefselremodellering
Researchers can explore additional educational content through the Frontier Peptide Research Library, which features articles covering peptide biology, molecular signaling, laboratory methodologies, analytical chemistry, peptide handling, and current peptide research topics
BPC-157, short for Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protein found in gastric juice
Red flags when evaluating suppliers include prices dramatically below market average, missing or generic Certificates of Analysis, no batch numbers or unclear sourcing information, and lack of responsive customer service
US$ 28.89
US$ 24.53
US$ 20.47
/assets/production/practices/91a656dbaed06a839d929dd58fbbd646e53f5ef7/images/2755432.jpeg)
US$ 29.89
US$ 22.81
/assets/production/practices/55360fce0f64baf345ad2884198670a0f635d38a/images/2763084.jpeg)
US$ 21.49
